An Open-label, Multi-center Study Evaluating the Validity, Reliability, and Responsiveness of a New Female-specific Angina Questionnaire in Women With Chronic Angina Treated With Ranolazine Extended-release Tablets (CVT 3041)

Total Heart Care, PC, New York

Albany Associates in Cardiology, Albany

Tri-State Medical Group, Cardiology, Sewickley Valley Medical Group, Cardiology, Beaver

Cardiology Consultants of Philadelphia, Philadelphia

Emory University & Grady Health System, Atlanta

Jacksonville Center for Clinical Research, Jacksonville

St. Luke Cardiology Associates, Jacksonville

Jacksonville Heart Center, PA, Jacksonville

Jacksonville Heart Center, PA, Jacksonville

Guerra Cardiology, Coral Gables

University of Louisville, Division of Cardiovascular Medicine, Louisville

Ashland Hospital Corporation d/b/a King's Daughters Medical Center, Ashland

St. Vincent Mercy Medical Center, Cardiac Research, Toledo

The Lindner Clinical Trial Center, Cincinnati

Northern Indiana Research Alliance, Fort Wayne

North Shore Cardiology, Bannockburn

Gateway Cardiology, P.C., Jerseyville

Gateway Cardiology, P.C., St Louis

Integrated Cardiology Consultants, LLC d.b.a. Bryan LGH Heart Institute, Lincoln

BlueStem Cardiology, Bartlesville

Mercy Physician Group Cardiology, Nampa

Cardiovascular Consultants, Ltd., Phoenix

Cedars-Sinai Medical Center, Los Angeles

Access Clinical Trials/Cardiovascular Research Institute (ACT/CVRI), Beverly Hills

Escondido Cardiology Associates, Escondido

Mission Internal Medical Group, Mission Viejo

Cardiology Consultants of Orange County, Anaheim

The University of Alabama at Birmingham, Birmingham

South Denver Cardiology Associates, PC, Littleton